Overview

Healthcare Distribution Services Market Introduction

Healthcare Distribution Market is estimated to value over USD 4.5 billion by 2027 end and register a CAGR of over 13% during the forecast period 2020 to 2027.

The worldwide market for healthcare distribution involves storage and transportation of pharmaceutical products from production units to the wholesalers, patients and hospitals. Manufacturers of pharmaceutical goods share strong ties with the suppliers of 3PL to allow the uptake of effective reasonably priced metrics.

The healthcare industry is mandated to follow the stringent public regulations due to the pharmaceutical goods being made available to patients in usable modes and the rigid guidelines ensures their safety records are accomplished by healthcare pharmaceutical goods. In different circumstances, businesses may also wish to carry out their distribution endeavours through outsourcing. The global market growth is primarily driven by the high volume of chronic illness, lucrative investments in research and development endeavours, growing emphasis on generics, and innovations in the medical equipment industry.

The pharmaceutical goods distribution services segment holds the maximum global market share primarily because of the boost in the production of pharmaceutical endeavours, growing research and development expenditure, the deploying of pharmaceutical manufacturing to Asian nations and the implementation of new manufacturing units by international companies in new geographical locations.

Market analysis shows that the retail pharmacies hold the largest market shares. In fact, these pharmacies receive a significant number of prescriptions on a day-to-day basis. Furthermore, the US as well as other developed nations, have enacted programs to provide cost-effective healthcare for citizens. Due to this reason, there has been a robust growth in the number of prescriptions in retail pharmacies.

Key players that dominate the market includes:

FFF Enterprises (US), Owens & Minor, Inc. (US), McKesson Corporation (US), Mutual Drug (US), CuraScript SD (US), Rochester Drug Cooperative, Inc. (US), Medline Industries (US), Patterson Companies Inc. (US), AmerisourceBergen Corporation (US), Morris and Dickson Co., LLC (US), Henry Schein Inc. (US), Smith Drug Company (US), Cardinal Health, Inc. (US), Shanghai Pharmaceutical Group Co., Ltd. (China), Henry Schein Inc. (US), PHOENIX Group (Germany), and KeySource Medical, Inc. (US).

healthcare distribution market

Healthcare Distribution Services Market Segmentation:

By Type

Over-The-Counter Drugs/Vitamins
Brand-Name/Innovator Drugs
Generic Drugs
Medical Device Distribution Services
Biopharmaceutical Product Distribution Services
Monoclonal Antibodies
Vaccines
Recombinant Proteins
Blood and Blood Products
Other Products

By End User

Retail Pharmacies
Hospital Pharmacies
Other End Users

By Region

Europe
North America
Asia Pacific
Rest of the World

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the market by type, by end user and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, industry-specific restraints and opportunities)
To forecast and evaluate micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa
To record , evaluate and analyze competitive landscape mapping- technological advancements, product launches, expansions and mergers